The primary goal of the work proposed here is to establish the structure of the propeptides of two genetic types of procollagens, Type I and Type II. Type I procollagen, the biosynthetic precursor of Type I collagen, is synthesized by many tissues including skin, tendon and bone. The Type II procollagen is the precursor of Type II collagen in hyaline cartilage, nucleus pulposus, intervertebral discs and sclera. The complete amino acid sequence of the carboxyl and amino propeptides of proAlpha1(I), proAlpha2(I) and proAlpha1(II) chains will be determined. In addition, we will attempt to determine the structure of the """"""""signal"""""""" sequences at the amino termini of the initial translation products of the three kinds of proAlpha-chains. To accomplish these goals, we will use a combination of peptide and DNA sequencing. The propeptides will be isolated from organ cultures of chick embryo tendons and sterna. The DNA will include cDNA complementary to propeptide regions of Type I and Type II-specific mRNA, purified and amplified by molecular cloning in E. coli strain HB101, as well as fragments of the proAlpha(I), proAlpha(2), and proAlpha1(II) genes isolated from genomic libraries. We will continue to work mostly with chick procollagens. However, in a comparison of propeptide structures among different animal species we will also characterize the proppeptides of human Type II procollagen. This will be done by isolation of human Type II collagen cDNA and gene clones and nucleotide sequencing of such clones. The long-term objective of these studies is to understand the structure of procollagen propeptides as it relates to their possible functions (intracellular folding of procollagen molecules, transport and secretion of procollagen, collagen fiber-formation and possibly regulation of collagen biosynthesis). In addition, through the isolation and characterization of the Type II procollagen genes we hope to build a basis for future studies of the modulated expression of this gene in normal development and its altered expression in disease states that involve hyaline cartilage such as osteoarthritis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR036819-02
Application #
3157741
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1985-07-01
Project End
1986-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Hu, Kai; Olsen, Bjorn R; Besschetnova, Tatiana Y (2017) Cell autonomous ANTXR1-mediated regulation of extracellular matrix components in primary fibroblasts. Matrix Biol 62:105-114
Nagao, Masashi; Hamilton, John L; Kc, Ranjan et al. (2017) Vascular Endothelial Growth Factor in Cartilage Development and Osteoarthritis. Sci Rep 7:13027
Hu, Kai; Olsen, Bjorn R (2017) Vascular endothelial growth factor control mechanisms in skeletal growth and repair. Dev Dyn 246:227-234
Hu, Kai; Besschetnova, Tatiana Y; Olsen, Bjorn R (2017) Soluble VEGFR1 reverses BMP2 inhibition of intramembranous ossification during healing of cortical bone defects. J Orthop Res 35:1461-1469
Olsen, Bjorn R; Berendsen, Agnes D; Besschetnova, Tatiana Y et al. (2016) Fell-Muir Lecture: Regulatory mechanisms of skeletal and connective tissue development and homeostasis - lessons from studies of human disorders. Int J Exp Pathol 97:296-302
Hu, Kai; Olsen, Bjorn R (2016) The roles of vascular endothelial growth factor in bone repair and regeneration. Bone 91:30-8
Huang, Wei; Li, Qing; Amiry-Moghaddam, Mahmood et al. (2016) Critical Endothelial Regulation by LRP5 during Retinal Vascular Development. PLoS One 11:e0152833
Duan, Xuchen; Bradbury, Seth R; Olsen, Bjorn R et al. (2016) VEGF stimulates intramembranous bone formation during craniofacial skeletal development. Matrix Biol 52-54:127-140
Nagao, M; Cheong, C W; Olsen, B R (2016) Col2-Cre and tamoxifen-inducible Col2-CreER target different cell populations in the knee joint. Osteoarthritis Cartilage 24:188-91
Hamilton, John L; Nagao, Masashi; Levine, Brett R et al. (2016) Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain. J Bone Miner Res 31:911-24

Showing the most recent 10 out of 152 publications